Member Info for Laura2022

Only £2.2mln

Definitely read across from AGL cancer diagnostic tools and what PYC are doing

Particularly in the USA market via DoseMeRx and PYC partnership

At £2.2mln market cap there is a lot of scope for upside

As let previous posts....I'm sure they will update soon on the pipeline

November Presentation

there was a good  slide fron Peter which broke down the 36 project into various sections and that pipeline was £1mln and can be a "top up process" into this pot. The current cash of over £700,000 is good for the foreseeable future and not less than 12-15mths  He said there are 9 of these which are ready to be signed. He re iterated the information from the annual report that they are targeting their best ever revenues (£1.0mln+ ) having already secured about £300k since June 2023 and with Merck back on board in August 2023 whom accounted for 40% of previous revenues (therefore about £300-400k) He expects that Merck will continue be a key client for PYC going forward 

Also stated they would inform the market if these were to be beaten .

A) pipeline of potential new contracts that could start in the current financial year which remains at over £1m despite four opportunities having been converted into signed projects during August

There are 9 contacts ready to be signed..I'm sure we'll hear soon newuncle

10 of top risers are bio techs

AGL also for cancer /oncology

C4XD RENE

Some good movers

Hny Newuncle

Some good news for bio techs last few days

Do people think thisos referring to the THX_VAL201

proceeds from the disposal shall be allocated in accordance with the financial strategy outlined by the CFO, with consideration given to reinvestment opportunities and shareholder valu

Apta moving well

HNY porky

You really are an objectionable man aren't you

1 I have no idea what you are talking about

2 you are doing the same deceitful antics you did on VAL for 12mths now on CREO and KNB....asking people for opinions them deceitful mentioning cash runway and placings in your replies

Your family must be proud

The "link has always been pretty clear as shown on 15th December

and we noted with interest the announcement by EUDA Health Holdings Inc in relation to its proposed merger with TheoremRx. We maintain regular lines of communications with the TheoremRx team

Gimme

HNY

It's all explained in the VAL operational update and the VAL presentation on BRR media

44th minute onwards

Have you listened?

Hny msuk

Can u update the chart please

Thanks KingH

LSE down since 8.00am

No trades showing almost everywhere

Hny homer

Have we had buys ?

Interesting point Trench

Do you think we ARE entitled to further payments

It was expected /supposition

Many expect a strong newsflow Q1 given 9 projects were merely awaiting signature (see Nov 17tth presentation on you tube )

Happy new year Trench/Aber

Licencing deal today

They are a long term client of PYC I think someone said

Great news today

New $5mln contract